FDAClass II · Drug · Recalled June 24, 2026

Circle K recall — Dabur India Limited

Hazard: CGMP Deviations; deficiencies observed during FDA inspection

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID: D-0631-2026
Brand: Dabur India
Classification: Class II
Units affected: 2420 tubes
Recall status: Ongoing
Initiated: Voluntary: Firm initiated

Description

Circle K, triple antibiotic ointment, Bacitracin Zinc (400 units), Neomycin Sulfate (3.5 mg), Polymyxin-B Sulfate (5000 units), net wt. 0.5 oz (14.2g) tubes, Product manufactured for Lil' Drug Store Products, Inc., 9300 Earhart Lane SW, Cedar Rapids, IA 52404, Made in India, UPC 1 94283 65181 0.

Affected products

Circle K

Companies & origin

Recalling firm location: Dadra And Nagar Haveli, India
Firm address: 225 - 4 - 1 Saily Village, Survey No, N/A

Identifying details (verbatim from the notice)

Product codes / lots: Lot# 0001, and Lot# 0005, within expiry
Distribution: US Nationwide.
Firm notified the public via: E-Mail
FDA event ID: 99137
Recall initiated: June 2, 2026
FDA classified: June 26, 2026
FDA report date: June 24, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 12:00 AM UTC.

Report a data error on this page